These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19022687)

  • 1. Matrix metalloproteinases in inflammatory pathologies of the horse.
    Clutterbuck AL; Harris P; Allaway D; Mobasheri A
    Vet J; 2010 Jan; 183(1):27-38. PubMed ID: 19022687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset.
    Kyaw-Tanner MT; Wattle O; van Eps AW; Pollitt CC
    Equine Vet J; 2008 Jul; 40(5):482-7. PubMed ID: 18178538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases.
    Abraham D; Ponticos M; Nagase H
    Curr Vasc Pharmacol; 2005 Oct; 3(4):369-79. PubMed ID: 16248781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.
    de Laat MA; Kyaw-Tanner MT; Nourian AR; McGowan CM; Sillence MN; Pollitt CC
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):275-81. PubMed ID: 21333362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
    Bourboulia D; Stetler-Stevenson WG
    Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
    Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
    Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting matrix metalloproteinases in inflammatory conditions.
    Clutterbuck AL; Asplin KE; Harris P; Allaway D; Mobasheri A
    Curr Drug Targets; 2009 Dec; 10(12):1245-54. PubMed ID: 19909233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases in the CNS: interferons get nervous.
    Chopra S; Overall CM; Dufour A
    Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of TIMPs in regulation of extracellular matrix proteolysis.
    Arpino V; Brock M; Gill SE
    Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinases in the Periodontium-Vital in Tissue Turnover and Unfortunate in Periodontitis.
    Radzki D; Negri A; Kusiak A; Obuchowski M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinases involved in matrix turnover during cartilage and bone breakdown.
    Cawston TE; Young DA
    Cell Tissue Res; 2010 Jan; 339(1):221-35. PubMed ID: 19915869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis].
    Yoshihara Y; Yamada H
    Clin Calcium; 2007 Apr; 17(4):500-8. PubMed ID: 17404478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.